Interesting reading here:
Below are the claims from Swami:
$LTP don't even own the underlying IP for their nasal erectile dysfunction that still has no patent. They paid $500k to license it & their maximum payout for license is US$3m. Hardly expecting a windfall I suggest The patent applications are already meeting with resistance
Erectile dysfunction solutions are as cheap as chips (27c a pill) these days & as easy to get. You don't need a prescription in some countries including NZ, England, & European countries & there is a push to switch to over the counter in others. $LTP looks a play on retail
Ann: LTR Pharma to List on the ASX, page-53
-
- There are more pages in this discussion • 94 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add LTP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.56 |
Change
0.025(1.63%) |
Mkt cap ! $132.2M | |||
| Open | High | Low | Value | Volume |
| $1.60 | $1.63 | $1.53 | $1.320M | 839.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3601 | $1.56 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.57 | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| LTP (ASX) Chart |